When to discontinue Dual-Energy X-ray Absorptiometry (DEXA) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Bone density testing with DEXA scans should be stopped when patients have demonstrated stable or improved bone density over multiple scans, typically after 2-5 years of stable results, or when the benefits no longer outweigh the risks, such as in patients with limited life expectancy or advanced age. When considering stopping DEXA scans, it's essential to weigh the benefits of continued monitoring against the potential risks and costs, including radiation exposure and healthcare expenses 1. For most patients, DEXA scans can be discontinued when they reach advanced age (usually over 80) or have very limited life expectancy (less than 5 years), as the results would not change clinical management 1. Some key points to consider when deciding to stop DEXA scans include:

  • Patients on treatment who demonstrate stable or improved bone density over multiple scans may not require continued monitoring 1
  • High-risk patients, such as those with previous fragility fractures, on medications causing bone loss, or with conditions affecting bone health, should continue regular monitoring 1
  • The typical interval between DEXA scans is 1-2 years when starting or changing treatments, extending to 2-5 years for stable patients 1
  • Discontinuing DEXA scans is appropriate when the results would not alter treatment decisions, as the radiation exposure and healthcare costs can be avoided when no clinical benefit remains 1. It's crucial to consider individual patient factors, such as bone health, medical history, and treatment response, when deciding to stop DEXA scans, rather than relying on a one-size-fits-all approach 1.

From the Research

Stopping Dexa Scan

  • There is no direct evidence on when to stop a Dexa scan, as the provided studies focus on osteoporosis treatment and bone density assessment rather than the duration of Dexa scans themselves 2, 3, 4, 5, 6.
  • However, it can be inferred that the decision to stop a Dexa scan may depend on the patient's response to treatment and their individual risk factors for osteoporosis 2, 3.
  • The frequency of Dexa scans is typically determined by the patient's bone density and risk of fracture, with more frequent scans recommended for those at higher risk 4, 6.
  • Studies have shown that transitioning from one osteoporosis treatment to another can be effective in maintaining or improving bone density, but the optimal duration of treatment and scanning schedule is not well established 2, 5.
  • Ultimately, the decision to stop a Dexa scan should be made on a case-by-case basis, taking into account the patient's individual needs and medical history, as well as the potential benefits and risks of continued scanning 3, 4, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of osteoporosis after alendronate or risedronate.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016

Research

Polypharmacy in Osteoporosis Treatment.

Clinics in geriatric medicine, 2022

Research

Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2013

Research

Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.